If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its ...
The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives ...
First orphan designation ever granted to a condensate-modulating therapeuticBuilds on recent IND opening for DPTX3186, a ...
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...
Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight ...
The tablets are to reduce the risk of cardiovascular death, myocardial infarction (MI) and stroke in patients with acute ...
China Medical System Holdings ( ($HK:0867) ) just unveiled an announcement. China Medical System Holdings has announced that its subsidiary, ...
Sportschosun on MSN
AI New Drug Research Institute invites global scholars to give special lectures on AI-based autonomo...
The AI New Drug Research Institute of the Korea Pharmaceutical Bio Association will hold a 'Global SDL Master Lecture'. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback